Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S Bilgen Apraş"'
Autor:
Nur Banu Karaca, Meral Calguneri, P. Kisacik, D Göksülük, Levent Kilic, N Yağlı Vardar, Gamze Arın, Erdem Karabulut, Omer Karadag, Edibe Ünal, Ali İhsan Ertenli, D Özcan Aydın, S Bilgen Apraş, Umut Kalyoncu, Sedat Kiraz, Ali Akdogan, A. Erden, U. Berberoglu
Publikováno v:
Abstracts Accepted for Publication.
Background Exercise programs have been being provided in Hacettepe University for 12 years. The group exercises were transformed into a book named as “Bilissel Egzersiz Terapi Yaklasimi (BETY) (1)” in 2014 and were registered as a trademark by th
Autor:
M Baykal, Ali Akdogan, Sedat Kiraz, E. Seyhoglu, Omer Karadag, Berkan Armagan, S Ak, Alper Sari, S Bilgen Apraş, Umut Kalyoncu, Levent Kilic, Ihsan Ertenli, Oğuz Abdullah Uyaroğlu, A. Erden
Publikováno v:
Abstracts Accepted for Publication.
Background Patients treated with biologic agents have increased risk of developing active tuberculosis (TB). It is essential to screen patients for latent TB before starting a biologic drug. Population is vaccinated with BCG in Turkey and BCG vaccina
Autor:
Omer Karadag, S Ak, Ihsan Ertenli, Oğuz Abdullah Uyaroğlu, A. Erden, Sedat Kiraz, Berkan Armagan, Levent Kılıç, Alper Sari, S Bilgen Apraş, Umut Kalyoncu, E. Seyhoglu, Ali Akdogan, M Baykal
Publikováno v:
Poster Presentations.
Autor:
Omer Karadag, E. Seyhoglu, Ihsan Ertenli, Oğuz Abdullah Uyaroğlu, A. Erden, Alper Sari, Levent Kilic, S Bilgen Apraş, Umut Kalyoncu, Ali Akdogan, Sedat Kiraz, Berkan Armagan
Publikováno v:
Poster Presentations.
Background A significant part of patients with inflammatory arthritis are at their reproductive ages. Biological drugs are one of the important treatment options for inflammatory artritis which can cause fetal morbidity and mortality. Management of a